Recruiting Pediatric Cancer Studies in Little Rock
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in chi...
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled ...
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and...
Neuroblastoma Maintenance Therapy Trial
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluo...
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FH...
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study in combination with etoposide for subjects with relapsed/refractory neuroblastoma....
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
The purpose of this study is to evaluate the investigational drug, tipifarnib (a pill taken by mouth), in combination with the Food and Drug Administration (FDA) approved drug, naxitimab, administered...
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
This is a prospective, multicenter clinical trial in subjects with newly diagnosed high-risk neuroblastoma to evaluate the efficacy and safety of administering naxitamab with standard induction therap...
About Pediatric Cancer Clinical Trials in Little Rock
Pediatric cancers include a wide range of cancers occurring in children and adolescents, with leukemia, brain tumors, and lymphoma being most common. Overall cure rates have improved dramatically to about 80%. Treatment includes chemotherapy, surgery, radiation, and newer immunotherapies.
There are currently 8 pediatric cancer clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 3,653 participants. Research is being sponsored by Children's Oncology Group, Giselle Sholler, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.
Pediatric Cancer Clinical Trials in Little Rock — FAQ
Are there pediatric cancer clinical trials in Little Rock?
Yes, there are 8 pediatric cancer clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Little Rock?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.
Are clinical trials in Little Rock free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.
What pediatric cancer treatments are being tested?
The 8 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for pediatric cancer.
Data updated March 2, 2026 from ClinicalTrials.gov